drugset / Trial / NCT06754943
To Evaluate the Safety and PK Characteristics After Co-administration of JW0104 and C2402 and Administration of JW0105
RandomizedCrossoverOpen-labelTreatment
Summary
The objective is to evaluate the safety and pharmacokinetic characteristics after co-administration of JW0104 and C2402 and administration of JW0105 in healthy volunteers under fasting conditions.
Timeline
- Start
- 2025-01-17
- Primary completion
- 2025-03-24
- Completion
- 2025-04-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | C2402 | Unknown | — | Oral |
| Subject | JW0104 | Unknown | — | Oral |
| Subject | JW0105 | Unknown | — | Oral |
Indications
No indication recorded.